Both in Pharmaceuticals
BridgeBio Oncology Therapeutics vs Oramed Pharmaceuticals
Over the past year BBOT returned −81.0% and ORMP returned +81.1%; their daily moves had a correlation of 0.26.
BBOT −81.0% ORMP +81.1%Growth of $1, one year, split-adjusted
| Metric | BBOT | ORMP |
|---|---|---|
| Price | $2.30 | $4.13 |
| Market cap | $184.4M | $171.8M |
| Today | −0.86% | +3.25% |
| 1 month | −34.3% | −5.7% |
| 6 months | −72.4% | +5.4% |
| Year to date | −81.6% | +44.9% |
| 1 year | −81.3% | +75.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | 1.0× |
| Price / sales | — | — |
| Net cash | $225.7M | $50.6M |
| Dividend yield | — | 6.05% |
| Volatility (60d) | 87.9% | 36.4% |
| Short % of float | 13.9% | 4.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).